🔎 Trials Near Me

Hem › Neuroblastom › Pennsylvania › Philadelphia

Kliniska studier för Neuroblastom i Philadelphia, PA

9 studier för Neuroblastom söker deltagare vid platser i och runt Philadelphia (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.

Officiell studietext (engelska)

Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

RekryterarFas 3
  • Children's Hospital of Philadelphia, Philadelphia
  • Saint Christopher's Hospital for Children, Philadelphia
  • Alfred I duPont Hospital for Children, Wilmington · 25 mi bort
Upp till ålder 30 · Alla kön · Uppdaterad 2 okt. 2026 · NCT06172296

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

RekryterarFas 1/2
  • Children's Hospital of Philadelphia (CHOP) ( Site 1021), Philadelphia
6 Months – 25 Years · Alla kön · Uppdaterad 17 sep. 2026 · NCT06395103

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

RekryterarFas 3
  • Children's Hospital of Philadelphia, Philadelphia
  • Alfred I duPont Hospital for Children, Wilmington · 25 mi bort
365 Days – 30 Years · Alla kön · Uppdaterad 25 aug. 2026 · NCT03126916

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

RekryterarFas 1/2
  • Children's Hospital of Philadelphia, Philadelphia
12 Months – 30 Years · Alla kön · Uppdaterad 25 aug. 2026 · NCT04851119

SPEARHEAD-3 Pediatric Study

RekryterarFas 1/2
  • Children's Hospital of Philedephia, Philadelphia
Ålder 2 till 21 · Alla kön · Uppdaterad 11 aug. 2026 · NCT05642455

PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors

RekryterarFas 1/2
  • Children's Hospital of Philadelphia, Philadelphia
Ålder 1 till 30 · Alla kön · Uppdaterad 22 juli 2026 · NCT06721689

NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial

RekryterarFas 2
  • Children's Hospital of Philadelphia, Philadelphia
Ålder 1 till 31 · Alla kön · Uppdaterad 20 juli 2026 · NCT06450041

Neuroblastoma Biology Study

RekryterarObservationsstudie
  • Children's Hospital of Philadelphia, Philadelphia
31 Days – 99 Years · Alla kön · Uppdaterad 23 mars 2026 · NCT01587300

Resource Intervention to Support Equity (RISE) in High-Risk Neuroblastoma

Rekryterar
  • Children's Hospital of Philadelphia, Philadelphia
Upp till ålder 17 · Alla kön · Uppdaterad 10 feb. 2026 · NCT06831552

Neuroblastom-studier i andra städer

Andra studier i Philadelphia

Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.